Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage: US Phase IIA Trial
- 1 January 2006
- journal article
- research article
- Published by Springer Nature in Neurocritical Care
- Vol. 4 (3) , 206-214
- https://doi.org/10.1385/ncc:4:3:206
Abstract
Background and Purpose Ultra-early hemostatic therapy may improve outcome after intracerebral hemorrhage (ICH) by preventing rebleeding and hematoma expansion. We conducted this trial to evaluate the...Keywords
This publication has 23 references indexed in Scilit:
- Recombinant Activated Factor VII for the Rapid Correction of Coagulopathy in Nonhemophilic Neurosurgical PatientsNeurosurgery, 2003
- Ultra-Early Hemostatic Therapy for Intracerebral HemorrhageStroke, 2003
- Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialThe Lancet, 2003
- Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in ratsJournal of Neurosurgery, 1998
- The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0Blood Coagulation & Fibrinolysis, 1998
- Enlargement of Spontaneous Intracerebral HemorrhageStroke, 1996
- Edema from intracerebral hemorrhage: the role of thrombinJournal of Neurosurgery, 1996
- Hematoma enlargement in spontaneous intracerebral hemorrhageJournal of Neurosurgery, 1994
- Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa)Blood Coagulation & Fibrinolysis, 1993
- Early heparin therapy in patients with spontaneous intracerebral haemorrhage.Journal of Neurology, Neurosurgery & Psychiatry, 1991